S

Smith & Nephew plc
D

SNN

25.410
USD
-0.30
(-1.15%)
Market Open
Volume
2,253
EPS
2
Div Yield
2.92
P/E
36
Market Cap
11,087,323,834
Related Instruments
    ABBV
    ABBV
    -2.650
    (-1.54%)
    169.770 USD
    AMGN
    AMGN
    -0.58
    (-0.21%)
    273.89 USD
    BMY
    BMY
    -0.400
    (-0.70%)
    56.650 USD
    GILD
    GILD
    -0.430
    (-0.46%)
    92.520 USD
    GSK
    GSK
    -0.070
    (-0.21%)
    33.710 USD
    JNJ
    JNJ
    -4.415
    (-2.98%)
    143.410 USD
    LLY
    LLY
    5.92
    (0.80%)
    750.51 USD
    MRK
    MRK
    -0.250
    (-0.26%)
    95.760 USD
    NVS
    NVS
    -0.725
    (-0.73%)
    99.030 USD
    PFE
    PFE
    -0.206
    (-0.77%)
    26.410 USD
    More
News

Title: Smith & Nephew plc

Sector: Healthcare
Industry: Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.